DEBORAH TERRIAN: Open Payments
NPI 1720335490 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 28 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $377 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $203 |
| Alkermes, Inc. | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Neurocrine BioSciences, Inc. | 4 | $72 |
| Tris Pharma Inc | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: COBENFY, INGREZZA, ARISTADA, REXULTI, LYBALVI, ABILIFY MAINTENA, Onyda XR, Secuado.
Industry payments across MI — which companies pay providers there.
